Physician profile
Robert A Bonner
NPI 1497862684
$3,627.09
in general payments reported to CMS, 2019-2025
17 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $542 · 2021: $522 · 2022: $639 · 2023: $493 · 2024: $484 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,036.96 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $749.03 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $406.61 | 2019-2025 | Ozempic, Rybelsus |
| Horizon Therapeutics Plc | $301.50 | 2022-2023 | Tepezza |
| Mannkind Corporation | $271.49 | 2019-2020 | |
| Lilly USA, LLC | $217.69 | 2022-2024 | Zepbound, Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $114.74 | 2023-2024 | |
| Amarin Pharma, INC. | $103.65 | 2019 | |
| Medtronic, INC. | $96.50 | 2023 | Minimed 780g |
| Janssen Pharmaceuticals, INC | $61.17 | 2019 | |
| Tandem Diabetes Care, INC. | $49.73 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $29.94 | 2024 | |
| Madrigal Pharmaceuticals | $23.94 | 2025 | Rezdiffra |
| Dexcom, INC. | $15.84 | 2025 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.27 | 2021 | |
| Merck Sharp & Dohme LLC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.